Study of Oral Vinorelbine Plus Capecitabine Versus Taxane-gemcitabine Combinations as 1st Line Chemotherapy in Metastatic Breast Cancer

• Status: Completed
• Trial end date: 2015-10-01

Summary

The aim of this international open-label randomized phase II trial is to evaluate the efficacy and safety of an all-oral combination and two all-intravenous combinations as first-line therapy for HER2-negative mBC patients.

• Phase: Phase 2

Details

• Lead Sponsor: Pierre Fabre Medicament
• Treatments: Albumin-Bound Paclitaxel; Capecitabine; Docetaxel; Gemcitabine; Paclitaxel; Vinorelbine